Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Paul Herzich

CTO at Solid Biosciences Inc. (SLDB)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $274K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 18SEC SLDBSolid Biosciences Inc. Sell Plan 3,61672,638 held (−5%) $5.82 $21K -5.0%
Feb 6SEC SLDBSolid Biosciences Inc. Sell Plan 10,90569,067 held (−14%) $6.44 $70K -14.1%
Feb 2SEC SLDBSolid Biosciences Inc. Sell Plan 26,25079,972 held (−25%) $6.44 $169K -14.1%
Dec 4SEC SLDBSolid Biosciences Inc. Sell Plan 2,70126,622 held (−9%) $5.11 $14K +8.2%
  • Sell

    CTO Paul Herzich sold $21K of SLDB at $5.82 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CTO Paul Herzich sold $70K of SLDB at $6.44 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CTO Paul Herzich sold $169K of SLDB at $6.44 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CTO Paul Herzich sold $14K of SLDB at $5.11 — pre-scheduled 10b5-1 plan sale.